Untitled document
Case
No judgment structure available for this case.
National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015)
made under subsection 84AAA(2) of the
National Health Act 1953
Compilation No. 41
Compilation date: 1 November 2019
Includes amendments up to: PB 86 of 2019
Registered: 8 November 2019
About this compilation
This compilation
This is a compilation of the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015) that shows the text of the law as amended and in force on 1 November 2019 (the compilation date).
The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.
Uncommenced amendments
The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register ( The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.
Application, saving and transitional provisions for provisions and amendments
If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.
Editorial changes
For more information about any editorial changes made in this compilation, see the endnotes.
Modifications
If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.
Self‑repealing provisions
If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.
Contents
1............ Name of Instrument....................................................................................................... 1
4............ Definitions..................................................................................................................... 1
5............ Specification of pharmaceutical items............................................................................ 1
6............ Circumstances relating to specification of pharmaceutical items.................................... 1
7............ Specification of period relating to a pharmaceutical benefit........................................... 2
Schedule 1—Pharmaceutical items and circumstances specified under subsection 84AAA(2) for purposes of early supply 3
Endnotes82
Endnote 1—About the endnotes 82
Endnote 2—Abbreviation key 83
Endnote 3—Legislation history 84
Endnote 4—Amendment history 86
1 Name of Instrument
(1) This Instrument is the National Health (Pharmaceutical benefits—early supply) Instrument 2015.
(2) This Instrument may also be cited as PB 120 of 2015.
4 Definitions
In this Instrument:
Act means the National Health Act 1953.
I.U. means international unit.
mg means milligram.
mL means millilitre.
g means grams.
pharmaceutical item has the meaning given by section 84AB of the Act.
pharmaceutical benefit has the meaning given by section 84 of the Act.
5 Specification of pharmaceutical items
For paragraph 84AAA(1)(a) of the Act, a pharmaceutical item in a pharmaceutical benefit is specified if:
(a) the listed drug and the form of that listed drug are mentioned in Schedule 1; and
(b) all the circumstances identified in section 6 as applying to the benefit exist in relation to a benefit that has the listed drug and form in Schedule 1.
Note: All pharmaceutical items have a manner of administration determined under subsection 85(5) of the Act, so the listed drug in that form with that manner of administration is specified.
6 Circumstances relating to specification of pharmaceutical items
For paragraph 5(b), the circumstances are as follows:
(1) the form mentioned in the table in Schedule 1 of a pharmaceutical benefit that has the listed drug is the same as the form determined under subsection 85(3) of the Act;
(2) the maximum quantity or number of units mentioned in the table in Schedule 1 for a benefit that has the listed drug and form is the same as the maximum quantity or number of units determined under paragraph 85A(2)(a) of the Act;
(3) the maximum number of repeats mentioned in the table in Schedule 1 for a benefit that has the listed drug and form is the same as the maximum number of repeats determined under paragraph 85A(2)(b) of the Act; and
(4) any other circumstance for paragraph 84AAA(3)(b) of the Act that is mentioned in the table in Schedule 1 for a benefit that has the listed drug and form.
7 Specification of period relating to a pharmaceutical benefit
For a pharmaceutical benefit that has the listed drug, the form of the listed drug, and the circumstances identified for section 6 in the table in Schedule 1, the number mentioned under the heading ‘Period’ is the period in days for paragraph 84AAA(1)(b) of the Act.
Schedule 1—Pharmaceutical items and circumstances specified under subsection 84AAA(2) for purposes of early supply
| Listed drug | Form | Period (days) | Circumstances: | ||
| Maximum quantity or number of units | Maximum number of repeats | Other circumstances (if any) | |||
| Abatacept | Injection 125 mg in 1 mL single dose autoinjector | 20 | 4 | 5 | |
| Injection 125 mg in 1 mL single dose pre‑filled syringe | 20 | 4 | 5 | ||
| Abiraterone | Tablet containing abiraterone acetate 250 mg | 20 | 120 | 2 | |
| Tablet containing abiraterone acetate 500 mg | 20 | 60 | 2 | ||
| Aciclovir | Tablet 200 mg | 20 | 90 | 5 | |
| Aclidinium | Powder for oral inhalation in breath actuated device 322 micrograms (as bromide) per dose, 60 doses | 20 | 1 | 5 | |
| Aclidinium with formoterol | Powder for oral inhalation in breath actuated device containing aclidinium 340 micrograms (as bromide) with formoterol fumarate dihydrate 12 micrograms per dose, 60 doses | 20 | 1 | 5 | |
| Adalimumab | Injection 20 mg in 0.4 mL pre‑filled syringe | 20 | 2 | 0 | |
| 20 | 2 | 3 | |||
| 20 | 2 | 5 | |||
| Injection 40 mg in 0.8 mL pre‑filled pen | 20 | 2 | 0 | ||
| 20 | 2 | 2 | |||
| 20 | 2 | 5 | |||
| Injection 40 mg in 0.8 mL pre‑filled pen, 4 | 20 | 1 | 5 | ||
| Injection 40 mg in 0.8 mL pre‑filled pen, 6 | 20 | 1 | 0 | ||
| Injection 40 mg in 0.8 mL pre‑filled syringe | 20 | 2 | 0 | ||
| 20 | 2 | 2 | |||
| 20 | 2 | 5 | |||
| Injection 40 mg in 0.8 mL pre‑filled syringe, 6 | 20 | 1 | 0 | ||
| Alendronic acid | Tablet 70 mg (as alendronate sodium) | 20 | 4 | 5 | |
| Alendronic acid with colecalciferol | Tablet 70 mg (as alendronate sodium) with 70 micrograms colecalciferol | 20 | 4 | 5 | |
| Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol | 20 | 4 | 5 | ||
| Alendronic acid with colecalciferol and calcium | Pack containing 4 tablets containing alendronic acid 70 mg (as alendronate sodium) with 140 micrograms colecalciferol and 48 tablets calcium 500 mg (as carbonate) | 20 | 1 | 5 | |
| Allopurinol | Tablet 100 mg | 20 | 200 | 2 | |
| Tablet 300 mg | 20 | 60 | 2 | ||
| Alogliptin | Tablet 6.25 mg (as benzoate) | 20 | 28 | 5 | |
| Tablet 12.5 mg (as benzoate) | 20 | 28 | 5 | ||
| Tablet 25 mg (as benzoate) | 20 | 28 | 5 | ||
| Alogliptin with metformin | Tablet containing 12.5 mg alogliptin (as benzoate) with 500 mg metformin hydrochloride | 20 | 56 | 5 | |
| Tablet containing 12.5 mg alogliptin (as benzoate) with 850 mg metformin hydrochloride | 20 | 56 | 5 | ||
| Tablet containing 12.5 mg alogliptin (as benzoate) with 1 g metformin hydrochloride | 20 | 56 | 5 | ||
| Amantadine | Capsule containing amantadine hydrochloride 100 mg | 20 | 100 | 5 | |
| Amlodipine | Tablet 5 mg (as besilate) | 20 | 30 | 5 | |
| Tablet 10 mg (as besilate) | 20 | 30 | 5 | ||
| Amlodipine with atorvastatin | Tablet 5 mg amlodipine (as besilate) with 10 mg atorvastatin (as calcium) | 20 | 30 | 5 | |
| Tablet 5 mg amlodipine (as besilate) with 20 mg atorvastatin (as calcium) | 20 | 30 | 5 | ||
| Tablet 5 mg amlodipine (as besilate) with 40 mg atorvastatin (as calcium) | 20 | 30 | 5 | ||
| Tablet 5 mg amlodipine (as besilate) with 80 mg atorvastatin (as calcium) | 20 | 30 | 5 | ||
| Tablet 10 mg amlodipine (as besilate) with 10 mg atorvastatin (as calcium) | 20 | 30 | 5 | ||
| Tablet 10 mg amlodipine (as besilate) with 20 mg atorvastatin (as calcium) | 20 | 30 | 5 | ||
| Tablet 10 mg amlodipine (as besilate) with 40 mg atorvastatin (as calcium) | 20 | 30 | 5 | ||
| Tablet 10 mg amlodipine (as besilate) with 80 mg atorvastatin (as calcium) | 20 | 30 | 5 | ||
| Amlodipine with valsartan | Tablet 5 mg (as besilate)‑80 mg | 20 | 28 | 5 | |
| Tablet 5 mg (as besilate)‑160 mg | 20 | 28 | 5 | ||
| Tablet 5 mg (as besilate)‑320 mg | 20 | 28 | 5 | ||
| Tablet 10 mg (as besilate)‑160 mg | 20 | 28 | 5 | ||
| Tablet 10 mg (as besilate)‑320 mg | 20 | 28 | 5 | ||
| Amlodipine with valsartan and hydrochlorothiazide | Tablet 5 mg (as besilate)‑160 mg‑12.5 mg | 20 | 28 | 5 | |
| Tablet 5 mg (as besilate)‑160 mg‑25 mg | 20 | 28 | 5 | ||
| Tablet 10 mg (as besilate)‑160 mg‑12.5 mg | 20 | 28 | 5 | ||
| Tablet 10 mg (as besilate)‑160 mg‑25 mg | 20 | 28 | 5 | ||
| Tablet 10 mg (as besilate)‑320 mg‑25 mg | 20 | 28 | 5 | ||
| Anastrozole | Tablet 1 mg | 20 | 30 | 5 | |
| Apixaban | Tablet 2.5 mg | 20 | 60 | 0 | |
| 20 | 60 | 5 | |||
| Tablet 5 mg | 20 | 28 | 0 | ||
| 20 | 60 | 5 | |||
| Armodafinil | Tablet 50 mg | 20 | 60 | 5 | |
| Tablet 150 mg | 20 | 30 | 5 | ||
| Tablet 250 mg | 20 | 30 | 5 | ||
| Aspirin | Tablet 100 mg | 20 | 112 | 1 | |
| Tablet, dispersible, 300 mg | 20 | 96 | 0 | ||
| Atazanavir with cobicistat | Tablet containing 300 mg atazanavir and 150 mg cobicistat | 20 | 60 | 5 | |
| Atenolol | Oral solution 50 mg in 10 mL, 300 mL | 20 | 1 | 5 | |
| Tablet 50 mg | 20 | 30 | 5 | ||
| Atomoxetine | Capsule 10 mg (as hydrochloride) | 20 | 56 | 5 | |
| Capsule 18 mg (as hydrochloride) | 20 | 56 | 5 | ||
| Capsule 25 mg (as hydrochloride) | 20 | 56 | 5 | ||
| Capsule 40 mg (as hydrochloride) | 20 | 56 | 5 | ||
| Capsule 60 mg (as hydrochloride) | 20 | 56 | 5 | ||
| Capsule 80 mg (as hydrochloride) | 20 | 28 | 5 | ||
| Capsule 100 mg (as hydrochloride) | 20 | 28 | 5 | ||
| Atorvastatin | Tablet 10 mg (as calcium) | 20 | 30 | 5 | |
| 20 | 30 | 11 | |||
| Tablet 20 mg (as calcium) | 20 | 30 | 5 | ||
| 20 | 30 | 11 | |||
| Tablet 40 mg (as calcium) | 20 | 30 | 5 | ||
| 20 | 30 | 11 | |||
| Tablet 80 mg (as calcium) | 20 | 30 | 5 | ||
| 20 | 30 | 11 | |||
| Auranofin | Capsule 3 mg | 20 | 60 | 5 | |
| Tablet 3 mg | 20 | 60 | 5 | ||
| Aurothiomalate | Injection containing sodium aurothiomalate 20 mg | 20 | 10 | 1 | |
| Azathioprine | Tablet 25 mg | 20 | 100 | 5 | |
| Tablet 50 mg | 20 | 100 | 5 | ||
| Baclofen | Tablet 10 mg | 20 | 100 | 5 | |
| Tablet 25 mg | 20 | 100 | 5 | ||
| Balsalazide | Capsule containing balsalazide sodium 750 mg | 20 | 280 | 5 | |
| Baricitinib | Tablet 2 mg | 20 | 28 | 5 | |
| Tablet 4 mg | 20 | 28 | 5 | ||
| Betaine | Oral powder 180 g | 20 | 1 | 5 | |
| Betamethasone | Injection containing betamethasone acetate 3 mg with betamethasone sodium phosphate 3.9 mg in 1 mL | 20 | 5 | 0 | |
| Bicalutamide | Tablet 50 mg | 20 | 28 | 5 | |
| Bictegravir with emtricitabine with tenofovir alafenamide | Tablet containing bictegravir 50 mg with emtricitabine 200 mg with tenofovir alafenamide 25 mg | 20 | 60 | 5 | |
| Bisoprolol | Tablet containing bisoprolol fumarate 2.5 mg | 20 | 28 | 5 | |
| Tablet containing bisoprolol fumarate 5 mg | 20 | 28 | 5 | ||
| Tablet containing bisoprolol fumarate 10 mg | 20 | 28 | 5 | ||
| Brexpiprazole | Tablet 1 mg | 20 | 30 | 0 | |
| Tablet 2 mg | 20 | 30 | 5 | ||
| Tablet 3 mg | 20 | 30 | 5 | ||
| Tablet 4 mg | 20 | 30 | 5 | ||
| Brivaracetam | Oral solution 10 mg per mL, 300 mL | 20 | 1 | 5 | |
| Tablet 25 mg | 20 | 56 | 5 | ||
| Tablet 50 mg | 20 | 56 | 5 | ||
| Tablet 75 mg | 20 | 56 | 5 | ||
| Tablet 100 mg | 20 | 56 | 5 | ||
| Buprenorphine | Injection (modified release) 8 mg in 0.16 mL pre‑filled syringe | 20 | 1 | 0 | |
| Injection (modified release) 16 mg in 0.32 mL pre‑filled syringe | 20 | 1 | 0 | ||
| Injection (modified release) 24 mg in 0.48 mL pre‑filled syringe | 20 | 1 | 0 | ||
| Injection (modified release) 32 mg in 0.64 mL pre‑filled syringe | 20 | 1 | 0 | ||
| Injection (modified release) 64 mg in 0.18 mL pre‑filled syringe | 20 | 1 | 0 | ||
| Injection (modified release) 96 mg in 0.27 mL pre‑filled syringe | 20 | 1 | 0 | ||
| Injection (modified release) 128 mg in 0.36 mL pre‑filled syringe | 20 | 1 | 0 | ||
| Bupropion | Tablet containing bupropion hydrochloride 150 mg (sustained release) | 20 | 30 | 0 | |
| 20 | 90 | 0 | |||
| Cabergoline | Tablet 1 mg | 20 | 30 | 5 | |
| Tablet 2 mg | 20 | 30 | 5 | ||
| Cabozantinib | Tablet 20 mg | 20 | 30 | 2 | |
| 20 | 30 | 5 | |||
| Tablet 40 mg | 20 | 30 | 2 | ||
| 20 | 30 | 5 | |||
| Tablet 60 mg | 20 | 30 | 2 | ||
| 20 | 30 | 5 | |||
| Calcitonin salmon | Injection 100 I.U. in 1 mL | 20 | 15 | 5 | |
| Calcitriol | Capsule 0.25 microgram | 20 | 100 | 3 | |
| Calcium | Tablet 600 mg (as carbonate) | 20 | 240 | 1 | |
| Candesartan | Tablet containing candesartan cilexetil 4 mg | 20 | 30 | 5 | |
| Tablet containing candesartan cilexetil 8 mg | 20 | 30 | 5 | ||
| Tablet containing candesartan cilexetil 16 mg | 20 | 30 | 5 | ||
| Tablet containing candesartan cilexetil 32 mg | 20 | 30 | 5 | ||
| Candesartan with hydrochlorothiazide | Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg | 20 | 30 | 5 | |
| Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg | 20 | 30 | 5 | ||
| Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg | 20 | 30 | 5 | ||
| Captopril | Tablet 12.5 mg | 20 | 90 | 5 | |
| Tablet 25 mg | 20 | 90 | 5 | ||
| Tablet 50 mg | 20 | 90 | 5 | ||
| Carbamazepine | Tablet 100 mg | 20 | 200 | 0 | |
| 20 | 200 | 2 | |||
| Tablet 200 mg | 20 | 200 | 0 | ||
| 20 | 200 | 2 | |||
| Tablet 200 mg (controlled release) | 20 | 200 | 0 | ||
| 20 | 200 | 2 | |||
| Tablet 400 mg (controlled release) | 20 | 200 | 0 | ||
| 20 | 200 | 2 | |||
| Carvedilol | Tablet 6.25 mg | 20 | 60 | 5 | |
| Tablet 12.5 mg | 20 | 60 | 5 | ||
| Tablet 25 mg | 20 | 60 | 5 | ||
| Certolizumab pegol | Injection 200 mg in 1 mL single use pre‑filled syringe | 20 | 2 | 5 | |
| Solution for injection 200 mg in 1 mL pre‑filled pen | 20 | 2 | 5 | ||
| Cimetidine | Tablet 400 mg | 20 | 60 | 5 | |
| Citalopram | Tablet 20 mg (as hydrobromide) | 20 | 28 | 5 | |
| Tablet 40 mg (as hydrobromide) | 20 | 28 | 5 | ||
| Clonazepam | Tablet 2 mg | 20 | 200 | 2 | |
| Tablet 500 micrograms | 20 | 200 | 2 | ||
| Clonidine | Tablet containing clonidine hydrochloride 100 micrograms | 20 | 100 | 5 | |
| Tablet containing clonidine hydrochloride 150 micrograms | 20 | 100 | 5 | ||
| Clopidogrel | Tablet 75 mg (as besilate) | 20 | 28 | 5 | |
| Tablet 75 mg (as hydrogen sulfate) | 20 | 28 | 5 | ||
| Clopidogrel with aspirin | Tablet 75 mg (as hydrogen sulfate)‑100 mg | 20 | 30 | 5 | |
| Dabigatran etexilate | Capsule 75 mg (as mesilate) | 20 | 60 | 0 | |
| Capsule 110 mg (as mesilate) | 20 | 60 | 0 | ||
| 20 | 60 | 5 | |||
| Capsule 150 mg (as mesilate) | 20 | 60 | 5 | ||
| Daclatasvir | Tablet 30 mg | 20 | 28 | 2 | |
| 20 | 28 | 5 | |||
| Tablet 60 mg | 20 | 28 | 2 | ||
| 20 | 28 | 5 | |||
| Dalteparin | Injection containing dalteparin sodium 7,500 I.U. (anti‑Xa) in 0.75 mL single dose pre‑filled syringe | 20 | 30 | 5 | |
| Injection containing dalteparin sodium 10,000 I.U. (anti‑Xa) in 1 mL single dose pre‑filled syringe | 20 | 30 | 5 | ||
| Injection containing dalteparin sodium 12,500 I.U. (anti‑Xa) in 0.5 mL single dose pre‑filled syringe | 20 | 30 | 5 | ||
| Injection containing dalteparin sodium 15,000 I.U. (anti‑Xa) in 0.6 mL single dose pre‑filled syringe | 20 | 30 | 5 | ||
| Injection containing dalteparin sodium 18,000 I.U. (anti‑Xa) in 0.72 mL single dose pre‑filled syringe | 20 | 30 | 5 | ||
| Dapagliflozin | Tablet 10 mg (as propanediol monohydrate) | 20 | 28 | 5 | |
| Dapagliflozin with metformin | Tablet (modified release) containing 5 mg dapagliflozin (as propanediol monohydrate) with 1000 mg metformin hydrochloride | 20 | 56 | 5 | |
| Tablet (modified release) containing 10 mg dapagliflozin (as propanediol monohydrate) with 500 mg metformin hydrochloride | 20 | 28 | 5 | ||
| Tablet (modified release) containing 10 mg dapagliflozin (as propanediol monohydrate) with 1000 mg metformin hydrochloride | 20 | 28 | 5 | ||
| Dapsone | Tablet 25 mg | 20 | 100 | 1 | |
| Tablet 100 mg | 20 | 100 | 1 | ||
| Dasatinib | Tablet 20 mg | 20 | 60 | 2 | |
| 20 | 60 | 5 | |||
| Tablet 50 mg | 20 | 60 | 2 | ||
| 20 | 60 | 5 | |||
| Tablet 70 mg | 20 | 60 | 2 | ||
| 20 | 60 | 5 | |||
| Tablet 100 mg | 20 | 30 | 2 | ||
| 20 | 30 | 5 | |||
| Degarelix | Powder for injection 80 mg (as acetate), injection set | 20 | 1 | 5 | |
| Powder for injection 120 mg (as acetate), 2, injection set | 20 | 1 | 0 | ||
| Denosumab | Injection 60 mg in 1 mL pre‑filled syringe | 20 | 1 | 0 | |
| Desmopressin | Tablet containing desmopressin acetate 200 micrograms | 20 | 30 | 5 | |
| 20 | 90 | 5 | |||
| Wafer 120 micrograms (as acetate) | 20 | 30 | 5 | ||
| Wafer 240 micrograms (as acetate) | 20 | 30 | 5 | ||
| Desvenlafaxine | Tablet (extended release) 50 mg (as succinate) | 20 | 28 | 5 | |
| Tablet (extended release) 100 mg (as succinate) | 20 | 28 | 5 | ||
| Tablet (modified release) 50 mg | 20 | 28 | 5 | ||
| Tablet (modified release) 50 mg (as benzoate) | 20 | 28 | 5 | ||
| Tablet (modified release) 100 mg | 20 | 28 | 5 | ||
| Tablet (modified release) 100 mg (as benzoate) | 20 | 28 | 5 | ||
| Digoxin | Tablet 62.5 micrograms | 20 | 200 | 1 | |
| Tablet 250 micrograms | 20 | 100 | 1 | ||
| Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg | 20 | 30 | 5 | |
| Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg | 20 | 30 | 5 | ||
| Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg | 20 | 30 | 5 | ||
| Tablet containing diltiazem hydrochloride 60 mg | 20 | 90 | 5 | ||
| Dimethyl fumarate | Capsule (modified release) 240 mg | 20 | 56 | 5 | |
| Dipyridamole | Capsule 200 mg (sustained release) | 20 | 60 | 5 | |
| Dipyridamole with aspirin | Capsule 200 mg (sustained release)‑25 mg | 20 | 60 | 5 | |
| Dolutegravir with rilpivirine | Tablet containing dolutegravir 50 mg (as sodium) with rilpivirine 25 mg (as hydrochloride) | 20 | 60 | 5 | |
| Donepezil | Tablet containing donepezil hydrochloride 5 mg | 20 | 28 | 5 | |
| Tablet containing donepezil hydrochloride 10 mg | 20 | 28 | 5 | ||
| Dulaglutide | Injection 1.5 mg in 0.5 mL single dose pre‑filled pen | 20 | 4 | 5 | |
| Duloxetine | Capsule 60 mg (as hydrochloride) | 20 | 28 | 5 | |
| Dutasteride | Capsule 500 micrograms | 20 | 30 | 5 | |
| Dutasteride with tamsulosin | Capsule containing dutasteride 500 micrograms with tamsulosin hydrochloride 400 micrograms | 20 | 30 | 5 | |
| Empagliflozin | Tablet 10 mg | 20 | 30 | 5 | |
| Tablet 25 mg | 20 | 30 | 5 | ||
| Empagliflozin with linagliptin | Tablet containing 10 mg empagliflozin with 5 mg linagliptin | 20 | 30 | 5 | |
| Tablet containing 25 mg empagliflozin with 5 mg linagliptin | 20 | 30 | 5 | ||
| Empagliflozin with metformin | Tablet containing 5 mg empagliflozin with 500 mg metformin hydrochloride | 20 | 60 | 5 | |
| Tablet containing 5 mg empagliflozin with 1 g metformin hydrochloride | 20 | 60 | 5 | ||
| Tablet containing 12.5 mg empagliflozin with 500 mg metformin hydrochloride | 20 | 60 | 5 | ||
| Tablet containing 12.5 mg empagliflozin with 1 g metformin hydrochloride | 20 | 60 | 5 | ||
| Enalapril | Tablet containing enalapril maleate 5 mg | 20 | 30 | 5 | |
| Tablet containing enalapril maleate 10 mg | 20 | 30 | 5 | ||
| Tablet containing enalapril maleate 20 mg | 20 | 30 | 5 | ||
| Enalapril with hydrochlorothiazide | Tablet containing enalapril maleate 20 mg with hydrochlorothiazide 6 mg | 20 | 30 | 5 | |
| Entacapone | Tablet 200 mg | 20 | 200 | 4 | |
| Enzalutamide | Capsule 40 mg | 20 | 112 | 2 | |
| Eplerenone | Tablet 25 mg | 20 | 30 | 5 | |
| Tablet 50 mg | 20 | 30 | 5 | ||
| Eprosartan | Tablet 400 mg (as mesilate) | 20 | 56 | 5 | |
| Tablet 600 mg (as mesilate) | 20 | 28 | 5 | ||
| Eprosartan with hydrochlorothiazide | Tablet 600 mg eprosartan (as mesilate) with 12.5 mg hydrochlorothiazide | 20 | 28 | 5 | |
| Erlotinib | Tablet 25 mg (as hydrochloride) | 20 | 30 | 3 | |
| Tablet 100 mg (as hydrochloride) | 20 | 30 | 3 | ||
| Tablet 150 mg (as hydrochloride) | 20 | 30 | 3 | ||
| Ertugliflozin | Tablet 5 mg | 20 | 28 | 5 | |
| Tablet 15 mg | 20 | 28 | 5 | ||
| Ertugliflozin with metformin | Tablet containing 2.5 mg ertugliflozin with 500 mg metformin hydrochloride | 20 | 56 | 5 | |
| Tablet containing 2.5 mg ertugliflozin with 1 g metformin hydrochloride | 20 | 56 | 5 | ||
| Tablet containing 7.5 mg ertugliflozin with 500 mg metformin hydrochloride | 20 | 56 | 5 | ||
| Tablet containing 7.5 mg ertugliflozin with 1 g metformin hydrochloride | 20 | 56 | 5 | ||
| Ertugliflozin with sitagliptin | Tablet containing 5 mg ertugliflozin with 100 mg sitagliptin | 20 | 28 | 5 | |
| Tablet containing 15 mg ertugliflozin with 100 mg sitagliptin | 20 | 28 | 5 | ||
| Escitalopram | Tablet 10 mg (as oxalate) | 20 | 28 | 5 | |
| Tablet 20 mg (as oxalate) | 20 | 28 | 5 | ||
| Esomeprazole | Capsule (enteric) 20 mg (as magnesium) | 20 | 30 | 1 | |
| 20 | 30 | 5 | |||
| Capsule (enteric) 40 mg (as magnesium) | 20 | 30 | 1 | ||
| 20 | 30 | 5 | |||
| Tablet (enteric coated) 20 mg (as magnesium trihydrate) | 20 | 30 | 1 | ||
| 20 | 30 | 5 | |||
| Tablet (enteric coated) 40 mg (as magnesium trihydrate) | 20 | 30 | 1 | ||
| 20 | 30 | 5 | |||
| Esomeprazole and clarithromycin and amoxicillin | Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate) | 20 | 1 | 0 | |
| Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium trihydrate), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate) | 20 | 1 | 0 | ||
| Estradiol | Tablet 2 mg | 20 | 56 | 2 | |
| Tablet containing estradiol valerate 1 mg | 20 | 56 | 2 | ||
| Tablet containing estradiol valerate 2 mg | 20 | 56 | 2 | ||
| Transdermal gel 1 mg (as hemihydrate) in 1 g sachet, 28 | 20 | 1 | 5 | ||
| Transdermal patches 390 micrograms, 8 | 20 | 1 | 5 | ||
| Transdermal patches 585 micrograms, 8 | 20 | 1 | 5 | ||
| Transdermal patches 750 micrograms (as hemihydrate), 8 | 20 | 1 | 5 | ||
| Transdermal patches 780 micrograms, 8 | 20 | 1 | 5 | ||
| Transdermal patches 1.17 mg, 8 | 20 | 1 | 5 | ||
| Transdermal patches 1.5 mg (as hemihydrate), 8 | 20 | 1 | 5 | ||
| Transdermal patches 1.56 mg, 8 | 20 | 1 | 5 | ||
| Transdermal patches 2 mg, 4 | 20 | 1 | 5 | ||
| Transdermal patches 3 mg (as hemihydrate), 8 | 20 | 1 | 5 | ||
| Transdermal patches 3.8 mg, 4 | 20 | 1 | 5 | ||
| Transdermal patches 5.7 mg, 4 | 20 | 1 | 5 | ||
| Transdermal patches 7.6 mg, 4 | 20 | 1 | 5 | ||
| Estradiol and estradiol with dydrogesterone | Pack containing 14 tablets estradiol 1 mg and 14 tablets estradiol 1 mg with dydrogesterone 10 mg | 20 | 1 | 5 | |
| Pack containing 14 tablets estradiol 2 mg and 14 tablets estradiol 2 mg with dydrogesterone 10 mg | 20 | 1 | 5 | ||
| Estradiol and estradiol with norethisterone | Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate | 20 | 1 | 5 | |
| Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate | 20 | 1 | 5 | ||
| Estradiol with dydrogesterone | Tablet 1 mg‑5 mg | 20 | 28 | 5 | |
| Estradiol with norethisterone | Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8 | 20 | 1 | 5 | |
| Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8 | 20 | 1 | 5 | ||
| Etanercept | Injection 50 mg in 1 mL single use auto‑injector, 4 | 20 | 1 | 3 | |
| 20 | 1 | 5 | |||
| Injection set containing 4 vials powder for injection 25 mg and 4 pre‑filled syringes solvent 1 mL | 20 | 2 | 3 | ||
| 20 | 2 | 5 | |||
| Injections 50 mg in 1 mL single use pre‑filled syringes, 4 | 20 | 1 | 3 | ||
| 20 | 1 | 5 | |||
| Ethosuximide | Capsule 250 mg | 20 | 200 | 2 | |
| Etonogestrel | Subcutaneous implant 68 mg | 20 | 1 | 0 | |
| Evolocumab | Injection 140 mg in 1 mL single use pre‑filled pen | 20 | 2 | 5 | |
| 20 | 3 | 5 | |||
| Injection 420 mg in 3.5 mL single use pre‑filled cartridge | 20 | 1 | 5 | ||
| Exenatide | Injection (modified release) 2 mg single dose pre‑filled pen | 20 | 4 | 5 | |
| Injection solution 5 micrograms per dose in pre‑filled pen, 60 doses | 20 | 1 | 5 | ||
| Injection solution 10 micrograms per dose in pre‑filled pen, 60 doses | 20 | 1 | 5 | ||
| Ezetimibe | Tablet 10 mg | 20 | 30 | 5 | |
| Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) | 20 | 1 | 5 | |
| Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | 20 | 1 | 5 | ||
| Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | 20 | 1 | 5 | ||
| Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | 20 | 1 | 5 | ||
| Ezetimibe with atorvastatin | Tablet 10 mg‑10 mg | 20 | 30 | 5 | |
| Tablet 10 mg‑20 mg | 20 | 30 | 5 | ||
| Tablet 10 mg‑40 mg | 20 | 30 | 5 | ||
| Tablet 10 mg‑80 mg | 20 | 30 | 5 | ||
| Ezetimibe with simvastatin | Tablet 10 mg‑10 mg | 20 | 30 | 5 | |
| Tablet 10 mg‑20 mg | 20 | 30 | 5 | ||
| Tablet 10 mg‑40 mg | 20 | 30 | 5 | ||
| Tablet 10 mg‑80 mg | 20 | 30 | 5 | ||
| Famciclovir | Tablet 250 mg | 20 | 56 | 5 | |
| Tablet 500 mg | 20 | 56 | 5 | ||
| Famotidine | Tablet 20 mg | 20 | 60 | 5 | |
| Tablet 40 mg | 20 | 30 | 5 | ||
| Febuxostat | Tablet 80 mg | 20 | 28 | 5 | |
| Felodipine | Tablet 2.5 mg (extended release) | 20 | 30 | 5 | |
| Tablet 5 mg (extended release) | 20 | 30 | 5 | ||
| Tablet 10 mg (extended release) | 20 | 30 | 5 | ||
| Fenofibrate | Tablet 48 mg | 20 | 60 | 5 | |
| 20 | 60 | 11 | |||
| Tablet 145 mg | 20 | 30 | 5 | ||
| 20 | 30 | 11 | |||
| Fingolimod | Capsule 250 micrograms (as hydrochloride) | 20 | 28 | 5 | |
| Capsule 500 micrograms (as hydrochloride) | 20 | 28 | 5 | ||
| Fludarabine | Tablet containing fludarabine phosphate 10 mg | 20 | 20 | 5 | |
| Fludrocortisone | Tablet containing fludrocortisone acetate 100 micrograms | 20 | 200 | 1 | |
| Flutamide | Tablet 250 mg | 20 | 100 | 5 | |
| Fluticasone furoate | Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms per dose, 30 doses | 20 | 1 | 5 | |
| Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms per dose, 30 doses | 20 | 1 | 5 | ||
| Fluticasone furoate with umeclidinium and vilanterol | Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms with umeclidinium 62.5 micrograms (as bromide) and vilanterol 25 micrograms (as trifenatate) per dose, 30 doses | 20 | 1 | 5 | |
| Fluvastatin | Tablet (prolonged release) 80 mg (as sodium) | 20 | 28 | 5 | |
| 20 | 28 | 11 | |||
| Fluvoxamine | Tablet containing fluvoxamine maleate 50 mg | 20 | 30 | 5 | |
| Tablet containing fluvoxamine maleate 100 mg | 20 | 30 | 5 | ||
| Folic acid | Tablet 500 micrograms | 20 | 200 | 0 | |
| Tablet 5 mg | 20 | 200 | 1 | ||
| Fosinopril | Tablet containing fosinopril sodium 10 mg | 20 | 30 | 5 | |
| Tablet containing fosinopril sodium 20 mg | 20 | 30 | 5 | ||
| Fosinopril with hydrochlorothiazide | Tablet containing fosinopril sodium 20 mg with hydrochlorothiazide 12.5 mg | 20 | 30 | 5 | |
| Furosemide | Tablet 20 mg | 20 | 100 | 1 | |
| Tablet 40 mg | 20 | 100 | 1 | ||
| Gabapentin | Capsule 100 mg | 20 | 100 | 5 | |
| Capsule 300 mg | 20 | 100 | 5 | ||
| Capsule 400 mg | 20 | 100 | 5 | ||
| Tablet 600 mg | 20 | 100 | 5 | ||
| Tablet 800 mg | 20 | 100 | 5 | ||
| Galantamine | Capsule (prolonged release) 8 mg (as hydrobromide) | 20 | 28 | 5 | |
| Capsule (prolonged release) 16 mg (as hydrobromide) | 20 | 28 | 5 | ||
| Capsule (prolonged release) 24 mg (as hydrobromide) | 20 | 28 | 5 | ||
| Gemfibrozil | Tablet 600 mg | 20 | 60 | 5 | |
| 20 | 60 | 11 | |||
| Gliclazide | Tablet 60 mg (modified release) | 20 | 60 | 5 | |
| Tablet 80 mg | 20 | 100 | 5 | ||
| Glimepiride | Tablet 3 mg | 20 | 30 | 5 | |
| Tablet 4 mg | 20 | 30 | 5 | ||
| Glyceryl trinitrate | Transdermal patch 18 mg | 20 | 30 | 5 | |
| Transdermal patch 25 mg | 20 | 30 | 5 | ||
| Transdermal patch 36 mg | 20 | 30 | 5 | ||
| Transdermal patch 50 mg | 20 | 30 | 5 | ||
| Transdermal patch 54 mg | 20 | 30 | 5 | ||
| Glycopyrronium | Capsule containing powder for oral inhalation 50 micrograms (as bromide) (for use in Breezhaler) | 20 | 30 | 5 | |
| Golimumab | Injection 50 mg in 0.5 mL single use pre‑filled pen | 20 | 1 | 5 | |
| Injection 50 mg in 0.5 mL single use pre‑filled syringe | 20 | 1 | 5 | ||
| Injection 100 mg in 1 mL single use pre‑filled pen | 20 | 1 | 5 | ||
| Goserelin | Subcutaneous implant 3.6 mg (as acetate) in pre‑filled injection syringe | 20 | 1 | 5 | |
| Subcutaneous implant (long acting) 10.8 mg (as acetate) in pre‑filled injection syringe | 20 | 1 | 1 | ||
| Goserelin and bicalutamide | Pack containing 1 subcutaneous implant containing goserelin 3.6 mg (as acetate) in pre‑filled injection syringe and 28 tablets bicalutamide 50 mg | 20 | 1 | 5 | |
| Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre‑filled injection syringe and 28 tablets bicalutamide 50 mg | 20 | 1 | 0 | ||
| Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre‑filled injection syringe and 84 tablets bicalutamide 50 mg | 20 | 1 | 1 | ||
| Griseofulvin | Tablet 125 mg | 20 | 100 | 2 | |
| Guanfacine | Tablet 1 mg (as hydrochloride) | 20 | 28 | 5 | |
| Tablet 2 mg (as hydrochloride) | 20 | 28 | 5 | ||
| Tablet 3 mg (as hydrochloride) | 20 | 28 | 5 | ||
| Tablet 4 mg (as hydrochloride) | 20 | 28 | 5 | ||
| Hydrochlorothiazide | Tablet 25 mg | 20 | 100 | 1 | |
| Hydrochlorothiazide with amiloride | Tablet containing hydrochlorothiazide 50 mg with amiloride hydrochloride 5 mg | 20 | 100 | 1 | |
| Hydroxocobalamin | Injection 1 mg (as acetate) in 1 mL | 20 | 3 | 0 | |
| Injection 1 mg (as chloride) in 1 mL | 20 | 3 | 0 | ||
| Hydroxychloroquine | Tablet containing hydroxychloroquine sulfate 200 mg | 20 | 100 | 1 | |
| Ibandronic acid | Tablet 50 mg (as ibandronate sodium monohydrate) | 20 | 28 | 2 | |
| Ibrutinib | Capsule 140 mg | 20 | 90 | 5 | |
| 20 | 120 | 5 | |||
| Idelalisib | Tablet 100 mg | 20 | 60 | 5 | |
| Tablet 150 mg | 20 | 60 | 5 | ||
| Imatinib | Capsule 100 mg (as mesilate) | 20 | 60 | 2 | |
| 20 | 60 | 5 | |||
| Capsule 400 mg (as mesilate) | 20 | 30 | 2 | ||
| 20 | 30 | 5 | |||
| Tablet 100 mg (as mesilate) | 20 | 60 | 2 | ||
| 20 | 60 | 5 | |||
| Tablet 400 mg (as mesilate) | 20 | 30 | 2 | ||
| 20 | 30 | 5 | |||
| Indacaterol | Capsule containing powder for oral inhalation 150 micrograms (as maleate) (for use in Breezhaler) | 20 | 30 | 5 | |
| Capsule containing powder for oral inhalation 300 micrograms (as maleate) (for use in Breezhaler) | 20 | 30 | 5 | ||
| Indacaterol with glycopyrronium | Capsule containing powder for oral inhalation indacaterol 110 micrograms (as maleate) with glycopyrronium 50 micrograms (as bromide) (for use in Breezhaler) | 20 | 30 | 5 | |
| Indapamide | Tablet containing indapamide hemihydrate 1.5 mg (sustained release) | 20 | 90 | 1 | |
| Tablet containing indapamide hemihydrate 2.5 mg | 20 | 90 | 1 | ||
| Insulin aspart | Injection (human analogue) (fast acting) 100 units per mL, 10 mL vial | 20 | 5 | 2 | |
| Injection (human analogue) 100 units per mL, 10 mL vial | 20 | 5 | 2 | ||
| Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | 20 | 5 | 1 | ||
| Injections (human analogue) (fast acting), pre‑filled pen, 100 units per mL, 3 mL, 5 | 20 | 5 | 1 | ||
| Insulin aspart with insulin aspart protamine suspension | Injections (human analogue), cartridges, 30 units‑70 units per mL, 3 mL, 5 | 20 | 5 | 1 | |
| Insulin detemir | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | 20 | 5 | 1 | |
| Insulin glulisine | Injection (human analogue) 100 units per mL, 10 mL | 20 | 5 | 2 | |
| Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | 20 | 5 | 1 | ||
| Insulin isophane | Injection (human) 100 units per mL, 10 mL | 20 | 5 | 2 | |
| Injections (human), cartridges, 100 units per mL, 3 mL, 5 | 20 | 5 | 1 | ||
| Insulin lispro | Injection (human analogue) 100 units per mL, 10 mL vial | 20 | 5 | 2 | |
| Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | 20 | 5 | 1 | ||
| Injections (human analogue), pre‑filled pen, 200 units per mL, 3 mL, 5 | 20 | 5 | 1 | ||
| Insulin lispro with insulin lispro protamine suspension | Injections (human analogue), cartridges, 25 units‑75 units per mL, 3 mL, 5 | 20 | 5 | 1 | |
| Injections (human analogue), cartridges, 50 units‑50 units per mL, 3 mL, 5 | 20 | 5 | 1 | ||
| Insulin neutral | Injection (human) 100 units per mL, 10 mL | 20 | 5 | 2 | |
| Injections (human), cartridges, 100 units per mL, 3 mL, 5 | 20 | 5 | 1 | ||
| Insulin neutral with insulin isophane | Injection (human) 30 units‑70 units per mL, 10 mL | 20 | 5 | 2 | |
| Injections (human), cartridges, 30 units‑70 units per mL, 3 mL, 5 | 20 | 5 | 1 | ||
| Injections (human), cartridges, 50 units‑50 units per mL, 3 mL, 5 | 20 | 5 | 1 | ||
| Irbesartan | Tablet 75 mg | 20 | 30 | 5 | |
| Tablet 150 mg | 20 | 30 | 5 | ||
| Tablet 300 mg | 20 | 30 | 5 | ||
| Irbesartan with hydrochlorothiazide | Tablet 150 mg‑12.5 mg | 20 | 30 | 5 | |
| Tablet 300 mg‑12.5 mg | 20 | 30 | 5 | ||
| Tablet 300 mg‑25 mg | 20 | 30 | 5 | ||
| Isosorbide mononitrate | Tablet 60 mg (sustained release) | 20 | 30 | 5 | |
| Tablet 120 mg (sustained release) | 20 | 30 | 5 | ||
| Ivabradine | Tablet 5 mg (as hydrochloride) | 20 | 56 | 5 | |
| Tablet 7.5 mg (as hydrochloride) | 20 | 56 | 5 | ||
| Ixekizumab | Injection 80 mg in 1 mL single dose pre‑filled pen | 20 | 2 | 2 | |
| Ketoprofen | Capsule 200 mg (sustained release) | 20 | 28 | 0 | |
| 20 | 28 | 3 | |||
| Labetalol | Tablet containing labetalol hydrochloride 100 mg | 20 | 100 | 5 | |
| Tablet containing labetalol hydrochloride 200 mg | 20 | 100 | 5 | ||
| Lacosamide | Tablet 100 mg | 20 | 56 | 5 | |
| Tablet 150 mg | 20 | 56 | 5 | ||
| Tablet 200 mg | 20 | 56 | 5 | ||
| Lamotrigine | Tablet 5 mg | 20 | 56 | 5 | |
| Tablet 25 mg | 20 | 56 | 5 | ||
| Tablet 50 mg | 20 | 56 | 5 | ||
| Tablet 100 mg | 20 | 56 | 5 | ||
| Tablet 200 mg | 20 | 56 | 5 | ||
| Lansoprazole | Capsule 15 mg | 20 | 30 | 5 | |
| Capsule 30 mg | 20 | 28 | 1 | ||
| 20 | 28 | 5 | |||
| Tablet 15 mg (orally disintegrating) | 20 | 28 | 5 | ||
| Tablet 30 mg (orally disintegrating) | 20 | 28 | 1 | ||
| 20 | 28 | 5 | |||
| Ledipasvir with sofosbuvir | Tablet containing 90 mg ledipasvir with 400 mg sofosbuvir | 20 | 28 | 1 | |
| 20 | 28 | 2 | |||
| 20 | 28 | 5 | |||
| Leflunomide | Tablet 10 mg | 20 | 30 | 5 | |
| Tablet 20 mg | 20 | 30 | 5 | ||
| Lercanidipine | Tablet containing lercanidipine hydrochloride 10 mg | 20 | 28 | 5 | |
| Tablet containing lercanidipine hydrochloride 20 mg | 20 | 28 | 5 | ||
| Lercanidipine with enalapril | Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 10 mg | 20 | 28 | 5 | |
| Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 20 mg | 20 | 28 | 5 | ||
| Letrozole | Tablet 2.5 mg | 20 | 30 | 5 | |
| Leuprorelin | I.M. injection (3 month modified release), powder for injection containing leuprorelin acetate 30 mg with diluent in pre‑filled dual‑chamber syringe | 20 | 1 | 1 | |
| I.M. injection (modified release), powder for injection containing leuprorelin acetate 7.5 mg with diluent in pre‑filled dual‑chamber syringe | 20 | 1 | 5 | ||
| I.M. injection (modified release), powder for injection containing leuprorelin acetate 22.5 mg with diluent in pre‑filled dual‑chamber syringe | 20 | 1 | 1 | ||
| I.M. injection (modified release), powder for injection containing leuprorelin acetate 30 mg with diluent in pre‑filled dual‑chamber syringe | 20 | 1 | 1 | ||
| I.M. injection (modified release), powder for injection containing leuprorelin acetate 45 mg with diluent in pre‑filled dual‑chamber syringe | 20 | 1 | 0 | ||
| Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 7.5 mg, injection set | 20 | 1 | 5 | ||
| Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 22.5 mg, injection set | 20 | 1 | 1 | ||
| Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 30 mg, injection set | 20 | 1 | 1 | ||
| Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 45 mg, injection set | 20 | 1 | 0 | ||
| Leuprorelin and bicalutamide | Pack containing 1 syringe containing leuprorelin 7.5 mg (as acetate) and 28 tablets bicalutamide 50 mg | 20 | 1 | 5 | |
| Pack containing 1 syringe containing leuprorelin 22.5 mg (as acetate) and 28 tablets bicalutamide 50 mg | 20 | 1 | 0 | ||
| Pack containing 1 syringe containing leuprorelin 22.5 mg (as acetate) and 84 tablets bicalutamide 50 mg | 20 | 1 | 1 | ||
| Levetiracetam | Oral solution 100 mg per mL, 300 mL | 20 | 1 | 5 | |
| Tablet 250 mg | 20 | 60 | 5 | ||
| Tablet 500 mg | 20 | 60 | 5 | ||
| Tablet 1 g | 20 | 60 | 5 | ||
| Levodopa with carbidopa and entacapone | Tablet 50 mg‑12.5 mg (as monohydrate)‑200 mg | 20 | 200 | 4 | |
| Tablet 75 mg‑18.75 mg (as monohydrate)‑200 mg | 20 | 200 | 4 | ||
| Tablet 100 mg‑25 mg (as monohydrate)‑200 mg | 20 | 200 | 4 | ||
| Tablet 125 mg‑31.25 mg (as monohydrate)‑200 mg | 20 | 200 | 4 | ||
| Tablet 150 mg‑37.5 mg (as monohydrate)‑200 mg | 20 | 200 | 4 | ||
| Tablet 200 mg‑50 mg (as monohydrate)‑200 mg | 20 | 200 | 4 | ||
| Levonorgestrel | Intrauterine drug delivery system 52 mg | 20 | 1 | 0 | |
| Tablets 30 micrograms, 28 | 20 | 4 | 2 | ||
| Levonorgestrel with ethinylestradiol | Pack containing 6 tablets 50 micrograms‑30 micrograms, 5 tablets 75 micrograms‑40 micrograms, 10 tablets 125 micrograms‑30 micrograms and 7 inert tablets | 20 | 4 | 2 | |
| Pack containing 21 tablets 100 micrograms‑20 micrograms and 7 inert tablets | 20 | 4 | 2 | ||
| Pack containing 21 tablets 125 micrograms‑50 micrograms and 7 inert tablets | 20 | 4 | 2 | ||
| Pack containing 21 tablets 150 micrograms‑30 micrograms and 7 inert tablets | 20 | 4 | 2 | ||
| Levothyroxine | Tablet containing 50 micrograms anhydrous levothyroxine sodium | 20 | 200 | 1 | |
| Tablet containing 75 micrograms anhydrous levothyroxine sodium | 20 | 200 | 1 | ||
| Tablet containing 100 micrograms anhydrous levothyroxine sodium | 20 | 200 | 1 | ||
| Tablet containing 200 micrograms anhydrous levothyroxine sodium | 20 | 200 | 1 | |
| Linagliptin | Tablet 5 mg | 20 | 30 | 5 |
| Linagliptin with metformin | Tablet containing 2.5 mg linagliptin with 500 mg metformin hydrochloride | 20 | 60 | 5 |
| Tablet containing 2.5 mg linagliptin with 850 mg metformin hydrochloride | 20 | 60 | 5 | |
| Tablet containing 2.5 mg linagliptin with 1000 mg metformin hydrochloride | 20 | 60 | 5 | |
| Liothyronine | Tablet containing liothyronine sodium 20 micrograms | 20 | 100 | 2 |
| Lisdexamfetamine | Capsule containing lisdexamfetamine dimesilate 50 mg | 20 | 30 | 5 |
| Lisinopril | Tablet 5 mg | 20 | 30 | 5 |
| Tablet 10 mg | 20 | 30 | 5 | |
| Tablet 20 mg | 20 | 30 | 5 | |
| Losartan | Tablet containing losartan potassium 25 mg | 20 | 30 | 5 |
| Tablet containing losartan potassium 50 mg | 20 | 60 | 5 | |
| Medroxyprogesterone | Injection containing medroxyprogesterone acetate 150 mg in 1 mL | 20 | 1 | 1 |
| Tablet containing medroxyprogesterone acetate 5 mg | 20 | 56 | 2 | |
| Tablet containing medroxyprogesterone acetate 10 mg | 20 | 30 | 2 | |
| 20 | 100 | 2 | ||
| Meloxicam | Capsule 15 mg | 20 | 30 | 3 |
| Tablet 15 mg | 20 | 30 | 3 | |
| Memantine | Tablet containing memantine hydrochloride 10 mg | 20 | 56 | 5 |
| Tablet containing memantine hydrochloride 20 mg | 20 | 28 | 5 | |
| Mesalazine | Sachet containing granules, 500 mg per sachet | 20 | 200 | 5 |
| Sachet containing granules, 1 g per sachet | 20 | 100 | 5 | |
| Sachet containing granules, 1.5 g per sachet | 20 | 60 | 5 | |
| Sachet containing granules, 3 g per sachet | 20 | 30 | 5 | |
| Sachet containing prolonged release granules, 1 g per sachet | 20 | 120 | 5 | |
| Sachet containing prolonged release granules, 2 g per sachet | 20 | 60 | 5 | |
| Sachet containing prolonged release granules, 4 g per sachet | 20 | 30 | 5 | |
| Tablet 250 mg (enteric coated) | 20 | 100 | 5 | |
| Tablet 500 mg (enteric coated) | 20 | 200 | 5 | |
| Tablet 500 mg (prolonged release) | 20 | 200 | 5 | |
| Tablet 800 mg (enteric coated) | 20 | 180 | 5 | |
| Tablet 1 g (enteric coated) | 20 | 120 | 5 | |
| Tablet 1 g (prolonged release) | 20 | 120 | 5 | |
| Tablet 1.2 g (prolonged release) | 20 | 120 | 5 | |
| Metformin | Tablet containing metformin hydrochloride 500 mg | 20 | 100 | 5 |
| Tablet containing metformin hydrochloride 850 mg | 20 | 60 | 5 | |
| Tablet containing metformin hydrochloride 1 g | 20 | 90 | 5 | |
| Tablet (extended release) containing metformin hydrochloride 500 mg | 20 | 120 | 5 | |
| Tablet (extended release) containing metformin hydrochloride 1 g | 20 | 60 | 5 | |
| Metformin with glibenclamide | Tablet containing metformin hydrochloride 250 mg with glibenclamide 1.25 mg | 20 | 90 | 5 |
| Tablet containing metformin hydrochloride 500 mg with glibenclamide 2.5 mg | 20 | 90 | 5 | |
| Tablet containing metformin hydrochloride 500 mg with glibenclamide 5 mg | 20 | 90 | 5 | |
| Methotrexate | Injection 7.5 mg in 0.15 mL pre‑filled syringe | 20 | 4 | 5 |
| Injection 7.5 mg in 0.3 mL pre‑filled syringe | 20 | 4 | 5 | |
| Injection 10 mg in 0.2 mL pre‑filled syringe | 20 | 4 | 5 | |
| Injection 10 mg in 0.4 mL pre‑filled syringe | 20 | 4 | 5 | |
| Injection 15 mg in 0.3 mL pre‑filled syringe | 20 | 4 | 5 | |
| Injection 15 mg in 0.6 mL pre‑filled syringe | 20 | 4 | 5 | |
| Injection 20 mg in 0.4 mL pre‑filled syringe | 20 | 4 | 5 | |
| injection 20 mg in 0.8 mL pre‑filled syringe | 20 | 4 | 5 | |
| Injection 25 mg in 0.5 mL pre‑filled syringe | 20 | 4 | 5 | |
| Injection 25 mg in 1 mL pre‑filled syringe | 20 | 4 | 5 | |
| Methyldopa | Tablet 250 mg (as sesquihydrate) | 20 | 100 | 5 |
| Methylprednisolone | Injection containing methylprednisolone acetate 40 mg in 1 mL | 20 | 5 | 0 |
| Metoprolol | Tablet containing metoprolol tartrate 50 mg | 20 | 100 | 5 |
| Tablet containing metoprolol tartrate 100 mg | 20 | 60 | 5 | |
| Metoprolol succinate | Tablet 47.5 mg (controlled release) | 20 | 30 | 5 |
| Tablet 95 mg (controlled release) | 20 | 30 | 5 | |
| Tablet 190 mg (controlled release) | 20 | 30 | 5 | |
| Minocycline | Tablet 50 mg (as hydrochloride) | 20 | 60 | 5 |
| Minoxidil | Tablet 10 mg | 20 | 100 | 5 |
| Mirtazapine | Tablet 45 mg | 20 | 30 | 5 |
| Tablet 45 mg (orally disintegrating) | 20 | 30 | 5 | |
| Moclobemide | Tablet 150 mg | 20 | 60 | 5 |
| Tablet 300 mg | 20 | 60 | 5 | |
| Modafinil | Tablet 100 mg | 20 | 120 | 5 |
| Montelukast | Tablet, chewable, 4 mg (as sodium) | 20 | 28 | 5 |
| Tablet, chewable, 5 mg (as sodium) | 20 | 28 | 5 | |
| Moxonidine | Tablet 200 micrograms | 20 | 30 | 5 |
| Tablet 400 micrograms | 20 | 30 | 5 | |
| Nafarelin | Nasal spray (pump pack) 200 micrograms (as acetate) per dose, 60 doses | 20 | 1 | 5 |
| Naproxen | Tablet 750 mg (sustained release) | 20 | 28 | 0 |
| 20 | 28 | 3 | ||
| Tablet 1 g (sustained release) | 20 | 28 | 0 | |
| 20 | 28 | 3 | ||
| Nebivolol | Tablet 1.25 mg (as hydrochloride) | 20 | 56 | 5 |
| Tablet 5 mg (as hydrochloride) | 20 | 28 | 5 | |
| Tablet 10 mg (as hydrochloride) | 20 | 28 | 5 | |
| Nicorandil | Tablets 10 mg, 60 | 20 | 1 | 5 |
| Tablets 20 mg, 60 | 20 | 1 | 5 | |
| Nifedipine | Tablet 10 mg | 20 | 60 | 5 |
| Tablet 20 mg | 20 | 60 | 5 | |
| Tablet 20 mg (controlled release) | 20 | 30 | 5 | |
| Tablet 30 mg (controlled release) | 20 | 30 | 5 | |
| Tablet 60 mg (controlled release) | 20 | 30 | 5 | |
| Nilotinib | Capsule 150 mg (as hydrochloride monohydrate) | 20 | 120 | 5 |
| Capsule 200 mg (as hydrochloride monohydrate) | 20 | 120 | 5 | |
| Nilutamide | Tablet 150 mg | 20 | 30 | 5 |
| Nintedanib | Capsule 100 mg | 20 | 60 | 5 |
| Capsule 150 mg | 20 | 60 | 5 | |
| Nizatidine | Capsule 150 mg | 20 | 60 | 5 |
| Capsule 300 mg | 20 | 30 | 5 | |
| Norethisterone | Tablets 350 micrograms, 28 | 20 | 4 | 2 |
| Norethisterone with ethinylestradiol | Pack containing 21 tablets 500 micrograms‑35 micrograms and 7 inert tablets | 20 | 4 | 2 |
| Pack containing 21 tablets 1 mg‑35 micrograms and 7 inert tablets | 20 | 4 | 2 | |
| Norethisterone with mestranol | Pack containing 21 tablets 1 mg‑50 micrograms and 7 inert tablets | 20 | 4 | 2 |
| Olaparib | Capsule 50 mg | 20 | 448 | 5 |
| Tablet 100 mg | 20 | 112 | 5 | |
| Tablet 150 mg | 20 | 112 | 5 | |
| Olmesartan | Tablet containing olmesartan medoxomil 20 mg | 20 | 30 | 5 |
| Tablet containing olmesartan medoxomil 40 mg | 20 | 30 | 5 | |
| Olmesartan with amlodipine | Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate) | 20 | 30 | 5 |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) | 20 | 30 | 5 | |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) | 20 | 30 | 5 | |
| Olmesartan with amlodipine and hydrochlorothiazide | Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg | 20 | 30 | 5 |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg | 20 | 30 | 5 | |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 25 mg | 20 | 30 | 5 | |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 12.5 mg | 20 | 30 | 5 | |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 25 mg | 20 | 30 | 5 | |
| Olmesartan with hydrochlorothiazide | Tablet containing olmesartan medoxomil 20 mg with hydrochlorothiazide 12.5 mg | 20 | 30 | 5 |
| Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 12.5 mg | 20 | 30 | 5 | |
| Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 25 mg | 20 | 30 | 5 | |
| Olsalazine | Capsule containing olsalazine sodium 250 mg | 20 | 100 | 5 |
| Tablet containing olsalazine sodium 500 mg | 20 | 100 | 5 | |
| Omeprazole | Capsule 20 mg | 20 | 30 | 1 |
| 20 | 30 | 5 | ||
| Tablet 10 mg (as magnesium) | 20 | 30 | 5 | |
| Tablet 20 mg | 20 | 30 | 1 | |
| 20 | 30 | 5 | ||
| Tablet 20 mg (as magnesium) | 20 | 30 | 1 | |
| 20 | 30 | 5 | ||
| Oxcarbazepine | Tablet 600 mg | 20 | 100 | 5 |
| Oxprenolol | Tablet containing oxprenolol hydrochloride 40 mg | 20 | 100 | 5 |
| Oxybutynin | Tablet containing oxybutynin hydrochloride 5 mg | 20 | 100 | 5 |
| Transdermal patches 36 mg, 8 | 20 | 1 | 5 | |
| Palbociclib | Capsule 75 mg | 20 | 21 | 5 |
| Capsule 100 mg | 20 | 21 | 5 | |
| Capsule 125 mg | 20 | 21 | 5 | |
| Pantoprazole | Sachet containing granules 40 mg (as sodium sesquihydrate) | 20 | 30 | 1 |
| 20 | 30 | 5 | ||
| Tablet (enteric coated) 20 mg (as sodium sesquihydrate) | 20 | 30 | 5 | |
| Tablet (enteric coated) 40 mg (as sodium sesquihydrate) | 20 | 30 | 1 | |
| 20 | 30 | 5 | ||
| Paracetamol | Tablet 500 mg | 20 | 300 | 0 |
| Tablet 665 mg (modified release) | 20 | 192 | 5 | |
| Paroxetine | Tablet 20 mg (as hydrochloride) | 20 | 30 | 5 |
| Pazopanib | Tablet 200 mg (as hydrochloride) | 20 | 30 | 5 |
| 20 | 90 | 2 | ||
| 20 | 90 | 5 | ||
| Tablet 400 mg (as hydrochloride) | 20 | 30 | 5 | |
| 20 | 60 | 2 | ||
| 20 | 60 | 5 | ||
| Perampanel | Tablet 4 mg (as hemisesquihydrate) | 20 | 28 | 5 |
| Tablet 6 mg (as hemisesquihydrate) | 20 | 28 | 5 | |
| Tablet 8 mg (as hemisesquihydrate) | 20 | 28 | 5 | |
| Tablet 10 mg (as hemisesquihydrate) | 20 | 28 | 5 | |
| Tablet 12 mg (as hemisesquihydrate) | 20 | 28 | 5 | |
| Perhexiline | Tablet containing perhexiline maleate 100 mg | 20 | 100 | 5 |
| Perindopril | Tablet containing perindopril arginine 2.5 mg | 20 | 30 | 5 |
| Tablet containing perindopril arginine 5 mg | 20 | 30 | 5 | |
| Tablet containing perindopril arginine 10 mg | 20 | 30 | 5 | |
| Tablet containing perindopril erbumine 2 mg | 20 | 30 | 5 | |
| Tablet containing perindopril erbumine 4 mg | 20 | 30 | 5 | |
| Tablet containing perindopril erbumine 8 mg | 20 | 30 | 5 | |
| Perindopril with amlodipine | Tablet containing 5 mg perindopril arginine with 5 mg amlodipine (as besilate) | 20 | 30 | 5 |
| Tablet containing 5 mg perindopril arginine with 10 mg amlodipine (as besilate) | 20 | 30 | 5 | |
| Tablet containing 10 mg perindopril arginine with 5 mg amlodipine (as besilate) | 20 | 30 | 5 | |
| Tablet containing 10 mg perindopril arginine with 10 mg amlodipine (as besilate) | 20 | 30 | 5 | |
| Perindopril with indapamide | Tablet containing perindopril arginine 2.5 mg with indapamide hemihydrate 0.625 mg | 20 | 30 | 5 |
| Tablet containing perindopril arginine 5 mg with indapamide hemihydrate 1.25 mg | 20 | 30 | 5 | |
| Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg | 20 | 30 | 5 | |
| Phenobarbital | Tablet 30 mg | 20 | 200 | 4 |
| Phenoxybenzamine | Capsule containing 10 mg phenoxybenzamine hydrochloride | 20 | 100 | 5 |
| Capsule containing phenoxybenzamine hydrochloride 10 mg | 20 | 100 | 5 | |
| Phenytoin | Capsule containing phenytoin sodium 30 mg | 20 | 200 | 2 |
| Capsule containing phenytoin sodium 100 mg | 20 | 200 | 2 | |
| Tablet 50 mg | 20 | 200 | 2 | |
| Pindolol | Tablet 5 mg | 20 | 100 | 5 |
| Pioglitazone | Tablet 45 mg (as hydrochloride) | 20 | 28 | 5 |
| Pirfenidone | Capsule 267 mg | 20 | 270 | 5 |
| Tablet 267 mg | 20 | 270 | 5 | |
| Tablet 801mg | 20 | 90 | 5 | |
| Pizotifen | Tablet 500 micrograms (as malate) | 20 | 100 | 2 |
| Ponatinib | Tablet 15 mg (as hydrochloride) | 20 | 60 | 2 |
| 20 | 60 | 5 | ||
| Tablet 45 mg (as hydrochloride) | 20 | 30 | 2 | |
| 20 | 30 | 5 | ||
| Potassium chloride | Tablet 600 mg (sustained release) | 20 | 200 | 1 |
| Potassium chloride with potassium bicarbonate | Tablet, effervescent, 14 mmol potassium and 8 mmol chloride | 20 | 60 | 1 |
| Pramipexole | Tablet (extended release) containing pramipexole dihydrochloride monohydrate 1.5 mg | 20 | 30 | 5 |
| Tablet (extended release) containing pramipexole dihydrochloride monohydrate 2.25 mg | 20 | 30 | 5 | |
| Tablet (extended release) containing pramipexole dihydrochloride monohydrate 3 mg | 20 | 30 | 5 | |
| Tablet (extended release) containing pramipexole dihydrochloride monohydrate 3.75 mg | 20 | 30 | 5 | |
| Tablet (extended release) containing pramipexole dihydrochloride monohydrate 4.5 mg | 20 | 30 | 5 | |
| Prasugrel | Tablet 5 mg (as hydrochloride) | 20 | 28 | 5 |
| Tablet 10 mg (as hydrochloride) | 20 | 28 | 5 | |
| Pravastatin | Tablet containing pravastatin sodium 10 mg | 20 | 30 | 5 |
| 20 | 30 | 11 | ||
| Tablet containing pravastatin sodium 20 mg | 20 | 30 | 5 | |
| 20 | 30 | 11 | ||
| Tablet containing pravastatin sodium 40 mg | 20 | 30 | 5 | |
| 20 | 30 | 11 | ||
| Tablet containing pravastatin sodium 80 mg | 20 | 30 | 5 | |
| 20 | 30 | 11 | ||
| Prazosin | Tablet 1 mg (as hydrochloride) | 20 | 100 | 5 |
| Tablet 2 mg (as hydrochloride) | 20 | 100 | 5 | |
| Tablet 5 mg (as hydrochloride) | 20 | 100 | 5 | |
| Pregabalin | Capsule 300 mg | 20 | 56 | 5 |
| Primidone | Tablet 250 mg | 20 | 200 | 2 |
| Probenecid | Tablet 500 mg | 20 | 100 | 5 |
| Propantheline | Tablet containing propantheline bromide 15 mg | 20 | 200 | 5 |
| Propranolol | Tablet containing propranolol hydrochloride 10 mg | 20 | 100 | 5 |
| Tablet containing propranolol hydrochloride 40 mg | 20 | 100 | 5 | |
| Tablet containing propranolol hydrochloride 160 mg | 20 | 50 | 5 | |
| Quinagolide | Tablet 75 micrograms (as hydrochloride) | 20 | 30 | 5 |
| Quinapril | Tablet 5 mg (as hydrochloride) | 20 | 30 | 5 |
| Tablet 10 mg (as hydrochloride) | 20 | 30 | 5 | |
| Tablet 20 mg (as hydrochloride) | 20 | 30 | 5 | |
| Quinapril with hydrochlorothiazide | Tablet 10 mg quinapril (as hydrochloride) with 12.5 mg hydrochlorothiazide | 20 | 30 | 5 |
| Tablet 20 mg quinapril (as hydrochloride) with 12.5 mg hydrochlorothiazide | 20 | 30 | 5 | |
| Rabeprazole | Tablet containing rabeprazole sodium 10 mg (enteric coated) | 20 | 28 | 5 |
| Tablet containing rabeprazole sodium 20 mg (enteric coated) | 20 | 30 | 1 | |
| 20 | 30 | 5 | ||
| Raloxifene | Tablet containing raloxifene hydrochloride 60 mg | 20 | 28 | 5 |
| Raltegravir | Tablet 600 mg (as potassium) | 20 | 120 | 5 |
| Ramipril | Capsule 1.25 mg | 20 | 30 | 5 |
| Capsule 2.5 mg | 20 | 30 | 5 | |
| Capsule 5 mg | 20 | 30 | 5 | |
| Capsule 10 mg | 20 | 30 | 5 | |
| Tablet 1.25 mg | 20 | 30 | 5 | |
| Tablet 2.5 mg | 20 | 30 | 5 | |
| Tablet 5 mg | 20 | 30 | 5 | |
| Tablet 10 mg | 20 | 30 | 5 | |
| Ramipril with felodipine | Tablet 2.5 mg‑2.5 mg (modified release) | 20 | 30 | 5 |
| Tablet 5 mg‑5 mg (modified release) | 20 | 30 | 5 | |
| Ranitidine | Syrup 150 mg (as hydrochloride) per 10 mL, 300 mL | 20 | 2 | 5 |
| Tablet 150 mg (as hydrochloride) | 20 | 60 | 5 | |
| Tablet 300 mg (as hydrochloride) | 20 | 30 | 5 | |
| Tablet, effervescent, 150 mg (as hydrochloride) | 20 | 60 | 5 | |
| Rasagiline | Tablet 1 mg (as mesilate) | 20 | 30 | 5 |
| Reboxetine | Tablet 4 mg (as mesilate) | 20 | 60 | 5 |
| Ribavirin | Tablet 400 mg | 20 | 28 | 2 |
| 20 | 28 | 5 | ||
| Tablet 600 mg | 20 | 28 | 2 | |
| 20 | 28 | 5 | ||
| Ribociclib | Tablet 200 mg | 20 | 21 | 5 |
| 20 | 42 | 5 | ||
| 20 | 63 | 5 | ||
| Rifaximin | Tablet 550 mg | 20 | 56 | 5 |
| Riluzole | Tablet 50 mg | 20 | 56 | 5 |
| Risedronic acid | Tablet containing risedronate sodium 5 mg | 20 | 28 | 5 |
| Tablet containing risedronate sodium 30 mg | 20 | 28 | 1 | |
| Tablet containing risedronate sodium 35 mg | 20 | 4 | 5 | |
| Tablet containing risedronate sodium 150 mg | 20 | 1 | 5 | |
| Tablet (enteric coated) containing risedronate sodium 35 mg | 20 | 4 | 5 | |
| Risedronic acid and calcium | Pack containing 4 tablets risedronate sodium 35 mg and 24 tablets calcium 500 mg (as carbonate) | 20 | 1 | 5 |
| Rivaroxaban | Tablet 10 mg | 20 | 30 | 5 |
| Tablet 15 mg | 20 | 28 | 5 | |
| Tablet 20 mg | 20 | 28 | 5 | |
| Rivastigmine | Capsule 1.5 mg (as hydrogen tartrate) | 20 | 56 | 5 |
| Capsule 3 mg (as hydrogen tartrate) | 20 | 56 | 5 | |
| Capsule 4.5 mg (as hydrogen tartrate) | 20 | 56 | 5 | |
| Capsule 6 mg (as hydrogen tartrate) | 20 | 56 | 5 | |
| Transdermal patch 9 mg | 20 | 30 | 5 | |
| Transdermal patch 18 mg | 20 | 30 | 5 | |
| Transdermal patch 27 mg | 20 | 30 | 5 | |
| Rosuvastatin | Tablet 5 mg (as calcium) | 20 | 30 | 5 |
| 20 | 30 | 11 | ||
| Tablet 10 mg (as calcium) | 20 | 30 | 5 | |
| 20 | 30 | 11 | ||
| Tablet 20 mg (as calcium) | 20 | 30 | 5 | |
| 20 | 30 | 11 | ||
| Tablet 40 mg (as calcium) | 20 | 30 | 5 | |
| 20 | 30 | 11 | ||
| Rotigotine | Transdermal patch 4.5 mg | 20 | 28 | 5 |
| Transdermal patch 9 mg | 20 | 28 | 5 | |
| Transdermal patch 13.5 mg | 20 | 28 | 5 | |
| Transdermal patch 18 mg | 20 | 28 | 5 | |
| Ruxolitinib | Tablet 5 mg | 20 | 112 | 0 |
| 20 | 112 | 5 | ||
| Tablet 10 mg | 20 | 56 | 0 | |
| 20 | 56 | 5 | ||
| Tablet 15 mg | 20 | 56 | 0 | |
| 20 | 56 | 5 | ||
| Tablet 20 mg | 20 | 56 | 0 | |
| 20 | 56 | 5 | ||
| Sacubitril with valsartan | Tablet containing sacubitril 24.3 mg with valsartan 25.7 mg | 20 | 56 | 5 |
| Tablet containing sacubitril 48.6 mg with valsartan 51.4 mg | 20 | 56 | 5 | |
| Tablet containing sacubitril 97.2 mg with valsartan 102.8 mg | 20 | 56 | 5 | |
| Safinamide | Tablet 50 mg | 20 | 30 | 5 |
| Tablet 100 mg | 20 | 30 | 5 | |
| Sapropterin | Tablet (soluble) containing sapropterin dihydrochloride 100 mg | 20 | 180 | 0 |
| 20 | 180 | 5 | ||
| Saxagliptin | Tablet 2.5 mg (as hydrochloride) | 20 | 28 | 5 |
| Tablet 5 mg (as hydrochloride) | 20 | 28 | 5 | |
| Saxagliptin with dapagliflozin | Tablet containing saxagliptin 5 mg with dapaglifozin 10 mg | 20 | 28 | 5 |
| Saxagliptin with metformin | Tablet (modified release) containing 2.5 mg saxagliptin (as hydrochloride) with 1000 mg metformin hydrochloride | 20 | 56 | 5 |
| Tablet (modified release) containing 5 mg saxagliptin (as hydrochloride) with 500 mg metformin hydrochloride | 20 | 28 | 5 | |
| Tablet (modified release) containing 5 mg saxagliptin (as hydrochloride) with 1000 mg metformin hydrochloride | 20 | 28 | 5 | |
| Secukinumab | Injection 150 mg in 1 mL pre‑filled pen | 20 | 1 | 5 |
| 20 | 2 | 5 | ||
| Selegiline | Tablet containing selegiline hydrochloride 5 mg | 20 | 100 | 5 |
| Sertraline | Tablet 50 mg (as hydrochloride) | 20 | 30 | 5 |
| Tablet 100 mg (as hydrochloride) | 20 | 30 | 5 | |
| Sevelamer | Tablet containing sevelamer hydrochloride 800 mg | 20 | 180 | 5 |
| Simvastatin | Tablet 5 mg | 20 | 30 | 5 |
| 20 | 30 | 11 | ||
| Tablet 10 mg | 20 | 30 | 5 | |
| 20 | 30 | 11 | ||
| Tablet 20 mg | 20 | 30 | 5 | |
| 20 | 30 | 11 | ||
| Tablet 40 mg | 20 | 30 | 5 | |
| 20 | 30 | 11 | ||
| Tablet 80 mg | 20 | 30 | 5 | |
| 20 | 30 | 11 | ||
| Sitagliptin | Tablet 25 mg (as phosphate monohydrate) | 20 | 28 | 5 |
| Tablet 50 mg (as phosphate monohydrate) | 20 | 28 | 5 | |
| Tablet 100 mg (as phosphate monohydrate) | 20 | 28 | 5 | |
| Sitagliptin with metformin | Tablet containing 50 mg sitagliptin (as phosphate monohydrate) with 500 mg metformin hydrochloride | 20 | 56 | 5 |
| Tablet containing 50 mg sitagliptin (as phosphate monohydrate) with 850 mg metformin hydrochloride | 20 | 56 | 5 | |
| Tablet containing 50 mg sitagliptin (as phosphate monohydrate) with 1000 mg metformin hydrochloride | 20 | 56 | 5 | |
| Tablet (modified release) containing 50 mg sitagliptin (as phosphate monohydrate) with 1000 mg metformin hydrochloride | 20 | 56 | 5 | |
| Tablet (modified release) containing 100 mg sitagliptin (as phosphate monohydrate) with 1000 mg metformin hydrochloride | 20 | 28 | 5 | |
| Sofosbuvir | Tablet 400 mg | 20 | 28 | 2 |
| 20 | 28 | 5 | ||
| Sonidegib | Capsule 200 mg | 20 | 30 | 3 |
| Sorafenib | Tablet 200 mg (as tosilate) | 20 | 120 | 2 |
| 20 | 120 | 5 | ||
| Spironolactone | Tablet 25 mg | 20 | 100 | 5 |
| Tablet 100 mg | 20 | 100 | 5 | |
| Sucralfate | Tablet equivalent to 1 g anhydrous sucralfate | 20 | 120 | 2 |
| Sulfasalazine | Tablet 500 mg | 20 | 200 | 5 |
| 20 | 200 | 11 | ||
| Tablet 500 mg (enteric coated) | 20 | 200 | 5 | |
| 20 | 200 | 11 | ||
| Sulthiame | Tablet 50 mg | 20 | 200 | 2 |
| Tablet 200 mg | 20 | 200 | 2 | |
| Sunitinib | Capsule 12.5 mg (as malate) | 20 | 28 | 1 |
| 20 | 28 | 2 | ||
| 20 | 28 | 3 | ||
| 20 | 28 | 5 | ||
| Capsule 25 mg (as malate) | 20 | 28 | 1 | |
| 20 | 28 | 2 | ||
| 20 | 28 | 3 | ||
| 20 | 28 | 5 | ||
| Capsule 37.5 mg (as malate) | 20 | 28 | 1 | |
| 20 | 28 | 2 | ||
| 20 | 28 | 3 | ||
| 20 | 28 | 5 | ||
| Capsule 50 mg (as malate) | 20 | 28 | 1 | |
| 20 | 28 | 2 | ||
| 20 | 28 | 3 | ||
| 20 | 28 | 5 | ||
| Tamoxifen | Tablet 10 mg (as citrate) | 20 | 60 | 5 |
| Tablet 20 mg (as citrate) | 20 | 30 | 5 | |
| 20 | 60 | 5 | ||
| Teduglutide | Powder for injection 5 mg with diluent | 20 | 28 | 0 |
| 20 | 28 | 5 | ||
| 20 | 28 | 11 | ||
| Telmisartan | Tablet 40 mg | 20 | 28 | 5 |
| Tablet 80 mg | 20 | 28 | 5 | |
| Telmisartan with amlodipine | Tablet 40 mg‑5 mg (as besilate) | 20 | 28 | 5 |
| Tablet 40 mg‑10 mg (as besilate) | 20 | 28 | 5 | |
| Tablet 80 mg‑5 mg (as besilate) | 20 | 28 | 5 | |
| Tablet 80 mg‑10 mg (as besilate) | 20 | 28 | 5 | |
| Telmisartan with hydrochlorothiazide | Tablet 40 mg‑12.5 mg | 20 | 28 | 5 |
| Tablet 80 mg‑12.5 mg | 20 | 28 | 5 | |
| Tablet 80 mg‑25 mg | 20 | 28 | 5 | |
| Temozolomide | Capsule 5 mg | 20 | 5 | 5 |
| 20 | 15 | 2 | ||
| Capsule 20 mg | 20 | 5 | 5 | |
| 20 | 15 | 2 | ||
| Capsule 100 mg | 20 | 5 | 5 | |
| 20 | 15 | 2 | ||
| Capsule 140 mg | 20 | 5 | 5 | |
| 20 | 15 | 2 | ||
| Capsule 180 mg | 20 | 5 | 5 | |
| Capsule 250 mg | 20 | 5 | 5 | |
| Tenofovir alafenamide with emtricitabine, elvitegravir and cobicistat | Tablet containing tenofovir alafenamide 10 mg with emtricitabine 200 mg, elvitegravir 150 mg and cobicistat 150 mg | 20 | 60 | 5 |
| Tenofovir with emtricitabine | Tablet containing tenofovir disoproxil fumarate 300 mg with emtricitabine 200 mg | 20 | 30 | 2 |
| Tablet containing tenofovir disoproxil maleate 300 mg with emtricitabine 200 mg | 20 | 30 | 2 | |
| Tablet containing tenofovir disoproxil phosphate 291 mg with emtricitabine 200 mg | 20 | 30 | 2 | |
| Terbinafine | Tablet 250 mg (as hydrochloride) | 20 | 42 | 0 |
| 20 | 42 | 1 | ||
| Teriflunomide | Tablet 14 mg | 20 | 28 | 5 |
| Teriparatide | Injection 250 micrograms per mL, 2.4 mL in multi‑dose pre‑filled pen | 20 | 1 | 5 |
| Testosterone | Capsule containing testosterone undecanoate 40 mg | 20 | 60 | 5 |
| I.M. injection containing testosterone undecanoate 1,000 mg in 4 mL | 20 | 1 | 1 | |
| Transdermal cream 50 mg per mL, 50 mL | 20 | 1 | 6 | |
| Transdermal gel 50 mg in 5 g sachet, 30 | 20 | 1 | 5 | |
| Transdermal gel (pump pack) 12.5 mg per 1.25 g dose, 60 doses, 2 | 20 | 1 | 4 | |
| Transdermal gel (pump pack) 23 mg per 1.15 g dose, 56 doses | 20 | 1 | 5 | |
| Transdermal patches 12.2 mg, 60 | 20 | 1 | 5 | |
| Transdermal patches 24.3 mg, 30 | 20 | 1 | 5 | |
| Tetrabenazine | Tablet 25 mg | 20 | 112 | 5 |
| Theophylline | Tablet 200 mg (sustained release) | 20 | 100 | 5 |
| Tablet 250 mg (sustained release) | 20 | 100 | 5 | |
| Tablet 300 mg (sustained release) | 20 | 100 | 5 | |
| Tiagabine | Tablet 5 mg (as hydrochloride) | 20 | 100 | 5 |
| Tablet 10 mg (as hydrochloride) | 20 | 100 | 5 | |
| Tablet 15 mg (as hydrochloride) | 20 | 100 | 5 | |
| Ticagrelor | Tablet 90 mg | 20 | 56 | 5 |
| Tiotropium | Capsule containing powder for oral inhalation 18 micrograms (as bromide monohydrate) (for use in HandiHaler) | 20 | 30 | 5 |
| Solution for oral inhalation 2.5 micrograms (as bromide monohydrate) per actuation (60 actuations) | 20 | 1 | 5 | |
| Tiotropium with olodaterol | Solution for oral inhalation containing tiotropium 2.5 micrograms (as bromide monohydrate) with olodaterol 2.5 micrograms (as hydrochloride) per dose, 60 doses | 20 | 1 | 5 |
| Tocilizumab | Injection 162 mg in 0.9 mL single use pre‑filled pen | 20 | 4 | 5 |
| 20 | 4 | 6 | ||
| Injection 162 mg in 0.9 mL single use pre‑filled syringe | 20 | 4 | 5 | |
| 20 | 4 | 6 | ||
| Tofacitinib | Tablet 5 mg | 20 | 56 | 5 |
| Topiramate | Capsule 15 mg | 20 | 60 | 5 |
| Capsule 25 mg | 20 | 60 | 5 | |
| Capsule 50 mg | 20 | 60 | 5 | |
| Tablet 25 mg | 20 | 60 | 5 | |
| Tablet 50 mg | 20 | 60 | 5 | |
| Tablet 100 mg | 20 | 60 | 5 | |
| Tablet 200 mg | 20 | 60 | 5 | |
| Trandolapril | Capsule 500 micrograms | 20 | 28 | 5 |
| Capsule 1 mg | 20 | 28 | 5 | |
| Capsule 2 mg | 20 | 28 | 5 | |
| Capsule 4 mg | 20 | 28 | 5 | |
| Trandolapril with verapamil | Tablet containing trandolapril 2 mg with verapamil hydrochloride 180 mg (sustained release) | 20 | 28 | 5 |
| Tablet containing trandolapril 4 mg with verapamil hydrochloride 240 mg (sustained release) | 20 | 28 | 5 | |
| Triamcinolone | Injection containing triamcinolone acetonide 10 mg in 1 mL | 20 | 5 | 0 |
| Trihexyphenidyl | Tablet containing trihexyphenidyl hydrochloride 2 mg | 20 | 200 | 2 |
| Tablet containing trihexyphenidyl hydrochloride 5 mg | 20 | 200 | 1 | |
| Triptorelin | Powder for I.M. injection (prolonged release) 3.75 mg (as embonate) with solvent, syringe and needles | 20 | 1 | 5 |
| Powder for I.M. injection (prolonged release) 11.25 mg (as embonate) with solvent, syringe and needles | 20 | 1 | 1 | |
| Powder for I.M. injection (prolonged release) 22.5 mg (as embonate) with solvent, syringe and needles | 20 | 1 | 0 | |
| Umeclidinium | Powder for oral inhalation in breath actuated device 62.5 micrograms (as bromide) per dose, 30 doses | 20 | 1 | 5 |
| Umeclidinium with vilanterol | Powder for oral inhalation in breath actuated device containing umeclidinium 62.5 micrograms (as bromide) with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses | 20 | 1 | 5 |
| Ustekinumab | Injection 45 mg in 0.5 mL | 20 | 1 | 1 |
| 20 | 1 | 2 | ||
| 20 | 2 | 0 | ||
| Valaciclovir | Tablet 500 mg (as hydrochloride) | 20 | 30 | 5 |
| Valproic acid | Tablet (enteric coated) containing sodium valproate 200 mg | 20 | 200 | 2 |
| Tablet (enteric coated) containing sodium valproate 500 mg | 20 | 200 | 2 | |
| Valsartan | Tablet 80 mg | 20 | 28 | 5 |
| Tablet 160 mg | 20 | 28 | 5 | |
| Tablet 320 mg | 20 | 28 | 5 | |
| Valsartan with hydrochlorothiazide | Tablet 80 mg‑12.5 mg | 20 | 28 | 5 |
| Tablet 160 mg‑12.5 mg | 20 | 28 | 5 | |
| Tablet 160 mg‑25 mg | 20 | 28 | 5 | |
| Tablet 320 mg‑12.5 mg | 20 | 28 | 5 | |
| Tablet 320 mg‑25 mg | 20 | 28 | 5 | |
| Varenicline | Box containing 11 tablets 0.5 mg (as tartrate) and 14 tablets 1 mg (as tartrate) in the first pack and 28 tablets 1 mg (as tartrate) in the second pack | 20 | 1 | 0 |
| Tablet 1 mg (as tartrate) | 20 | 56 | 2 | |
| 20 | 112 | 0 | ||
| Venetoclax | Tablet 100 mg | 20 | 120 | 5 |
| Venlafaxine | Capsule (modified release) 75 mg (as hydrochloride) | 20 | 28 | 5 |
| Capsule (modified release) 150 mg (as hydrochloride) | 20 | 28 | 5 | |
| Verapamil | Tablet containing verapamil hydrochloride 40 mg | 20 | 100 | 5 |
| Tablet containing verapamil hydrochloride 80 mg | 20 | 100 | 5 | |
| Tablet containing verapamil hydrochloride 180 mg (sustained release) | 20 | 30 | 5 | |
| Tablet containing verapamil hydrochloride 240 mg (sustained release) | 20 | 30 | 5 | |
| Vigabatrin | Oral powder, sachet 500 mg | 20 | 60 | 5 |
| Tablet 500 mg | 20 | 100 | 5 | |
| Vildagliptin | Tablet 50 mg | 20 | 60 | 5 |
| Vildagliptin with metformin | Tablet containing 50 mg vildagliptin with 500 mg metformin hydrochloride | 20 | 60 | 5 |
| Tablet containing 50 mg vildagliptin with 850 mg metformin hydrochloride | 20 | 60 | 5 | |
| Tablet containing 50 mg vildagliptin with 1000 mg metformin hydrochloride | 20 | 60 | 5 | |
| Vismodegib | Capsule 150 mg | 20 | 28 | 3 |
| Zonisamide | Capsule 25 mg | 20 | 56 | 5 |
| Capsule 50 mg | 20 | 56 | 5 | |
| Capsule 100 mg | 20 | 112 | 5 |
Endnotes
Endnote 1—About the endnotes
The endnotes provide information about this compilation and the compiled law.
The following endnotes are included in every compilation:
Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history
Abbreviation key—Endnote 2
The abbreviation key sets out abbreviations that may be used in the endnotes.
Legislation history and amendment history—Endnotes 3 and 4
Amending laws are annotated in the legislation history and amendment history.
The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.
The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.
Editorial changes
The Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and presentational changes to a compiled law in preparing a compilation of the law for registration. The changes must not change the effect of the law. Editorial changes take effect from the compilation registration date.
If the compilation includes editorial changes, the endnotes include a brief outline of the changes in general terms. Full details of any changes can be obtained from the Office of Parliamentary Counsel.
Misdescribed amendments
A misdescribed amendment is an amendment that does not accurately describe the amendment to be made. If, despite the misdescription, the amendment can be given effect as intended, the amendment is incorporated into the compiled law and the abbreviation “(md)” added to the details of the amendment included in the amendment history.
If a misdescribed amendment cannot be given effect as intended, the abbreviation “(md not incorp)” is added to the details of the amendment included in the amendment history.
Endnote 2—Abbreviation key
| ad = added or inserted | o = order(s) |
| am = amended | Ord = Ordinance |
| amdt = amendment | orig = original |
| c = clause(s) | par = paragraph(s)/subparagraph(s) |
| C[x] = Compilation No. x | /sub‑subparagraph(s) |
| Ch = Chapter(s) | pres = present |
| def = definition(s) | prev = previous |
| Dict = Dictionary | (prev…) = previously |
| disallowed = disallowed by Parliament | Pt = Part(s) |
| Div = Division(s) | r = regulation(s)/rule(s) |
| ed = editorial change | reloc = relocated |
| exp = expires/expired or ceases/ceased to have | renum = renumbered |
| effect | rep = repealed |
| F = Federal Register of Legislation | rs = repealed and substituted |
| gaz = gazette | s = section(s)/subsection(s) |
| LA = Legislation Act 2003 | Sch = Schedule(s) |
| LIA = Legislative Instruments Act 2003 | Sdiv = Subdivision(s) |
| (md) = misdescribed amendment can be given | SLI = Select Legislative Instrument |
| effect | SR = Statutory Rules |
| (md not incorp) = misdescribed amendment | Sub‑Ch = Sub‑Chapter(s) |
| cannot be given effect | SubPt = Subpart(s) |
| mod = modified/modification | underlining = whole or part not |
| No. = Number(s) | commenced or to be commenced |
Endnote 3—Legislation history
| Name | Registration | Commencement | Application, saving and transitional provisions |
| PB 120 of 2015 | 24 Dec 2015 (F2015L02129) | 1 Jan 2015 (s 2) | |
| PB 4 of 2016 | 1 Feb 2016 (F2016L00074) | 1 Feb 2016 (s 2) | — |
| PB 12 of 2016 | 1 Mar 2016 (F2016L00200) | 1 Mar 2016 (s 2) | — |
| PB 21 of 2016 | 1 Apr 2016 (F2016L00482) | 1 Apr 2016 (s 2) | — |
| PB 32 of 2016 | 29 Apr 2016 (F2016L00601) | 1 May 2016 (s 2) | — |
| PB 54 of 2016 | 22 June 2016 (F2016L01055) | 1 July 2016 (s 2) | — |
| PB 66 of 2016 | 19 July 2016 (F2016L01197) | 1 Aug 2016 (s 2) | — |
| PB 75 of 2016 | 18 Aug 2016 (F2016L01297) | 1 Sept 2016 (s 2) | — |
| PB 83 of 2016 | 30 Sept 2016 (F2016L01561) | 1 Oct 2016 (s 2) | — |
| PB 92 of 2016 | 31 Oct 2016 (F2016L01679) | 1 Nov 2016 (s 2) | — |
| PB 99 of 2016 | 30 Nov 2016 (F2016L01834) | 1 Dec 2016 (s 2) | — |
| PB 111 of 2016 | 22 Dec 2016 (F2016L02025) | 1 Jan 2017 (s 2) | — |
| PB 4 of 2017 | 25 Jan 2017 (F2017L00068) | 1 Feb 2017 (s 2) | — |
| PB 19 of 2017 | 30 Mar 2017 (F2017L00358) | 1 Apr 2017 (s 2) | — |
| PB 29 of 2017 | 28 Apr 2017 (F2017L00485) | 1 May 2017 (s 2) | — |
| PB 38 of 2017 | 31 May 2017 (F2017L00628) | 1 June 2017 (s 2) | — |
| PB 46 of 2017 | 28 June 2017 (F2017L00774) | 1 July 2017 (s 2) | — |
| PB 65 of 2017 | 30 Aug 2017 (F2017L01105) | 1 Sept 2017 (s 2) | — |
| PB 74 of 2017 | 27 Sept 2017 (F2017L01278) | 1 Oct 2017 (s 2) | — |
| PB 87 of 2017 | 24 Oct 2017 (F2017L01387) | 1 Nov 2017 (s 2) | — |
| PB 94 of 2017 | 29 Nov 2017 (F2017L01541) | 1 Dec 2017 (s 2) | — |
| PB 103 of 2017 | 18 Dec 2017 (F2017L01629) | 1 Jan 2018 (s 2) | — |
| PB 4 of 2018 | 24 Jan 2018 (F2018L00054) | 1 Feb 2018 (s 2) | — |
| PB 15 of 2018 | 28 Feb 2018 (F2018L00164) | 1 Mar 2018 (s 2) | — |
| PB 21 of 2018 | 28 Mar 2018 (F2018L00422) | 1 Apr 2018 (s 2) | — |
| PB 32 of 2018 | 30 Apr 2018 (F2018L00546) | 1 May 2018 (s 2) | — |
| PB 39 of 2018 | 31 May 2018 (F2018L00688) | 1 June 2018 (s 2) | — |
| PB 52 of 2018 | 29 June 2018 (F2018L00942) | 1 July 2018 (s 2) | — |
| PB 65 of 2018 | 1 Aug 2018 (F2018L01075) | 1 Aug 2018 (s 2) | — |
| PB 76 of 2018 | 30 Aug 2018 (F2018L01230) | 1 Sept 2018 (s 2) | — |
| PB 93 of 2018 | 29 Oct 2018 (F2018L01486) | 1 Nov 2018 (s 2) | — |
| PB 100 of 2018 | 29 Nov 2018 (F2018L01626) | 1 Dec 2018 (s 2) | — |
| PB 2 of 2019 | 31 Jan 2019 (F2019L00076) | 1 Feb 2019 (s 2) | — |
| PB 12 of 2019 | 27 Feb 2019 (F2019L00208) | 1 Mar 2019 (s 2) | — |
| PB 19 of 2019 | 28 Mar 2019 (F2019L00454) | 1 Apr 2019 (s 2) | — |
| PB 30 of 2019 | 30 Apr 2019 (F2019L00654) | 1 May 2019 (s 2) | — |
| PB 38 of 2019 | 30 May 2019 (F2019L00698) | 1 June 2019 (s 2) | — |
| PB 47 of 2019 | 28 June 2019 (F2019L00908) | 1 July 2019 (s 2) | — |
| PB 60 of 2019 | 29 July 2019 (F2019L01009) | 1 Aug 2019 (s 2) | — |
| PB 68 of 2019 | 30 Aug 2019 (F2019L01128) | 1 Sept 2019 (s 2) | — |
| PB 77 of 2019 | 30 Sept 2019 (F2019L01297) | 1 Oct 2019 (s 2) | — |
| PB 86 of 2019 | 31 Oct 2019 (F2019L01389) | 1 Nov 2019 (s 2) | — |
Endnote 4—Amendment history
| Provision affected | How affected |
| s 2............................................. | rep LIA s 48D |
| s 3............................................. | rep LIA s 48C |
| s 6............................................. | ed C26 |
| Schedule 1 | |
| Schedule 1................................ | am PB 4, 12, 21, 32, 54, 66, 75, 83, 92, 99 and 111 of 2016; PB 4 of 2017; PB 19 of 2017; PB 29 of 2017; PB 38 of 2017; PB 46 of 2017; PB 65 of 2017; PB 74 of 2017; PB 87 of 2017; PB 94 of 2017; PB 103 of 2017; PB 4 of 2018; PB 15 of 2018; PB 21 of 2018; PB 32 of 2018; PB 39 of 2018 |
| ed C26 | |
| am PB 52 of 2018; PB 65 of 2018; PB 76 of 2018; PB 93 of 2018 | |
| ed C30 | |
| am PB 100 of 2018; PB 2 of 2019; PB 12 of 2019 | |
| rs PB 19 of 2019 | |
| am PB 30 of 2019; PB 38 of 2019; PB 47 of 2019; PB 60 of 2019; PB 68 of 2019; PB 77 of 2019; PB 86 of 2019 |
Actions
Download as PDF
Download as Word Document
Citations
Untitled document
Cases Citing This Decision
0
Cases Cited
0
Statutory Material Cited
0